While some histological changes are irreversible, understanding these alterations can guide the development of targeted therapies. For instance, treatments aimed at reducing amyloid plaque formation in Alzheimer’s disease or enhancing dopaminergic function in Parkinson’s disease are being explored. Additionally, neuroprotective strategies that target glial cell function hold promise for mitigating disease progression.
